{"id":"W4323320185","doi":"10.1038/s41591-023-02222-w","title":"Evinacumab in severe hypertriglyceridemia with or without lipoprotein lipase pathway mutations: a phase 2 randomized trial","year":2023,"lang":"en","type":"article","venue":"Nature Medicine","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":130,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec; Université de Montréal","funders":"Kowa Company; Amarin Corporation; Esperion Therapeutics; Regeneron Pharmaceuticals; University of Pennsylvania; Amgen; BioClinica; Eli Lilly and Company","keywords":"Hypertriglyceridemia; Lipoprotein lipase; Medicine; Randomized controlled trial; Lipase; Internal medicine; Genetics; Endocrinology; Bioinformatics; Biology; Biochemistry; Enzyme; Triglyceride; Cholesterol","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001571034,0.001611708,0.002255818,0.0003490274,0.0003443754,0.001102543,0.0007492215,0.001815509,0.005248308],"category_scores_gemma":[0.001270879,0.0005789401,0.001602444,0.0003855367,0.0008232229,0.0007985306,0.0003691636,0.002606394,0.0006338369],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005909943,"about_ca_system_score_gemma":0.00106268,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000793246,"about_ca_topic_score_gemma":0.00167607,"domain_scores_codex":[0.9995271,0.0002684528,0.00002163852,0.00007243321,0.00003133863,0.00007897413],"domain_scores_gemma":[0.9994175,0.0001855208,0.0001221873,0.00004234387,0.00004338074,0.0001890394],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9746478,0.006493903,0.0007785355,0.0005742132,0.0009817281,0.00007105597,0.00003840504,0.0003644028,0.003230997,0.0001375417,0.001349437,0.01133191],"study_design_scores_gemma":[0.9685572,0.02902398,0.001045677,0.00002789295,0.0002734867,0.00002816614,0.00001481886,0.0003018958,0.0002099753,0.0001006236,0.0004068681,0.000009250532],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9843403,0.007120799,0.0006637357,0.001022534,0.0005978076,0.003215648,0.001071196,0.0001314424,0.001836567],"genre_scores_gemma":[0.9834135,0.003918299,0.001320117,0.001687521,0.0004827994,0.005300737,0.001190287,0.00002906701,0.002657723],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005248308,"threshold_uncertainty_score":0.01755732,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01863339277844512,"score_gpt":0.3402666791115156,"score_spread":0.3216332863330705,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}